Association for Molecular Pathology v. Myriad Genetics, Inc. and Its Impact on the Patentability of “Designer” Genes By Amanda H. Russo* Download a PDF version of this article here. Introduction I. The History of Assisted Reproductive Technologies A. Understanding Genetics & the Future of Biotechnology 1. Basic Genetic Concepts 2. Current Reproductive Biotechnologies a. In Vitro Fertilization and Pre-Implantation Genetic Diagnosis b. Cloning c. Somatic and Germ-line Gene Modification II. The Supreme Courts Decision in Association for Molecular Pathology v. Myriad Genetics, Inc. A. Procedural Posture of Myriad Genetics B. The Supreme Court’s Decision III. The Application of Myriad Genetics to Genetically Modified or Synthetic Gametes and Embryos A. The Emergence of Human Genes as a Topic in Patent Law B. Judicial Precedent on the Patentability of Living Organisms C. The Demise of the “Beneficial Utility” Requirement and the Introduction of the America Invents Act 1. The America Invents Act’s Prohibition on Patents for Inventions “Directed to or Encompassing Human Organisms.” Conclusion Continue reading →
